<rss version="2.0" xmlns:slash="http://purl.org/rss/1.0/modules/slash/">
<channel>
	<generator>Vivvo CMS 4.0</generator>
	<title>ILADS News</title>
	<link>http://www.ilads.org/news/</link>
	<copyright>&amp;copy;2007 Spoonlabs d.o.o.</copyright>
	<image>
		<title>ILADS News</title>
		<url>http://www.ilads.org/news/files.php?file=</url>
		<link>http://www.ilads.org/news/</link>
	</image>
	
			
				
					<item>
						<title>Nobel Laureate Dr. Luc Montagnier to speak at October 15 - 17th Lyme conference</title>
						<link>http://www.ilads.org/news/lyme_press_releases/77.html</link>
						<category>Press Releases</category>
						<pubDate>Mon, 30 Aug 2010 10:59:00 -0700</pubDate>
						<description>Nobel Laureate Dr. Luc Montagnier joins leaders in the Lyme disease community at this year&amp;#039;s 2010 ILADS professional conference</description>
					</item>
				
					<item>
						<title>Pennsylvania Senate Hearing</title>
						<link>http://www.ilads.org/news/lyme_legislation/74.html</link>
						<category>Legislation</category>
						<pubDate>Tue, 29 Jun 2010 21:59:00 -0700</pubDate>
						<description>Drs. Cameron, Maloney, Ostroff, and Kimball along with Julia F. Wagner, Gretchen and Meghan Harrison, and Pat Smith testify before the Senate Banking and Insurance Committee,  Senator Don White, Chairman, Tuesday, June 22, 2010</description>
					</item>
				
					<item>
						<title>Proof that chronic Lyme disease exists</title>
						<link>http://www.ilads.org/news/lyme_news/73.html</link>
						<category>News Coverage</category>
						<pubDate>Tue, 01 Jun 2010 08:19:00 -0700</pubDate>
						<description>The evidence continues to mount that Chronic Lyme Disease (CLD) exists and must be addressed by the medical community if solutions are to be found. Four National Institutes of Health (NIH) trials validated the existence and severity of CLD. Despite the evidence, there are physicians who continue to deny the existence and severity of CLD, which can hinder efforts to find a solution. Recognizing CLD could facilitate efforts to avoid diagnostic delays of two years and durations of illness of 4.7 to 9 years described in the NIH trials. The risk to society of emerging antibiotic-resistant organisms should be weighed against the societal risks associated with failing to treat an emerging population saddled with CLD. The mixed long-term outcome in children could also be examined. Once we accept the evidence that CLD exists, the medical community should be able to find solutions. Medical professionals should be encouraged to examine whether: (1) innovative treatments for early LD might prevent CLD, (2) early diagnosis of CLD might result in better treatment outcomes, and (3) more effective treatment regimens can be developed for CLD patients who have had prolonged illness and an associated poor quality of life.</description>
					</item>
				
					<item>
						<title>ASTONISHMENT AS MEDICAL PANEL RUBBER STAMPS ITS OWN CONTROVERSIAL GUIDELINES</title>
						<link>http://www.ilads.org/news/lyme_press_releases/72.html</link>
						<category>Press Releases</category>
						<pubDate>Tue, 27 Apr 2010 07:29:00 -0700</pubDate>
						<description>“It’s a sad day for the health care system and for everyone who suffers from the Lyme disease epidemic,” says Dr. Robert Bransfield, President of the International Lyme and Associated Diseases Society (ILADS).  “The IDSA’s flawed positions means patients will continue to suffer with incorrect diagnosis and improper treatment.”  Treatment guidelines are crucial when it comes to healthcare because they may dictate whether patients can get diagnosed and treated for illnesses and whether or not insurance companies will pay for it. </description>
					</item>
				
					<item>
						<title>Panel upholds controversial Lyme treatment guidelines</title>
						<link>http://www.ilads.org/news/lyme_news/70.html</link>
						<category>News Coverage</category>
						<pubDate>Thu, 22 Apr 2010 15:49:00 -0700</pubDate>
						<description>The eight-member review panel issued its report Thursday, unanimously agreeing to uphold the disease treatment guidelines developed in 2006 by the Arlington, Va.-based Infectious Diseases Society of America. The guidelines, among other things, don&amp;#039;t recommend treating Lyme disease with antibiotics for more than a few weeks and say there is no evidence that chronic Lyme disease exists.</description>
					</item>
				
					<item>
						<title>Review Panel Says Lyme Treatment Guidelines Don&#039;t Need To Change</title>
						<link>http://www.ilads.org/news/lyme_news/71.html</link>
						<category>News Coverage</category>
						<pubDate>Thu, 22 Apr 2010 16:49:00 -0700</pubDate>
						<description>Dr. Daniel Cameron, the immediate past president of the International Lyme and Associated Diseases Society, which acknowledges the existence of chronic Lyme disease, said he was disappointed but not surprised. Insurance companies may use the guidelines to deny coverage for long-term treatment, he said, but doctors will continue to see patients with chronic problems that require treatment.

&amp;quot;I don&amp;#039;t think the IDSA is going to continue to offer much leadership in terms of solving the chronic Lyme disease problem,&amp;quot; he said. &amp;quot;I don&amp;#039;t see them welcoming the challenges of somebody that&amp;#039;s been sick for months or years.&amp;quot;
</description>
					</item>
				
					<item>
						<title>Update on the ILADS Lyme Guidelines</title>
						<link>http://www.ilads.org/news/Educational/69.html</link>
						<category>Educational</category>
						<pubDate>Tue, 23 Feb 2010 05:48:00 -0800</pubDate>
						<description>Although the ILADS guidelines are no longer listed on the NGC, they have not expired.  The current guidelines will remain in effect until  they are replaced by ILADS revised guidelines, which ILADS is currently in the process of updating. </description>
					</item>
				
					<item>
						<title>ILADS, Chronic Lyme Community Cautiously Optimistic after Landmark Hearings </title>
						<link>http://www.ilads.org/news/lyme_press_releases/67.html</link>
						<category>Press Releases</category>
						<pubDate>Tue, 18 Aug 2009 04:03:00 -0700</pubDate>
						<description>Doctors and Patients Hope for Changes in Controversial Treatment Guidelines</description>
					</item>
				
					<item>
						<title>Lyme Disease Guidelines Revisted </title>
						<link>http://www.ilads.org/news/lyme_news/64.html</link>
						<category>News Coverage</category>
						<pubDate>Fri, 31 Jul 2009 06:54:00 -0700</pubDate>
						<description>Lyme disease advocate and Dr. Fletcher view the hearing </description>
					</item>
				
					<item>
						<title>Dialogue the key to solving the Lyme disease crisis</title>
						<link>http://www.ilads.org/news/freedom_to_practice/call_for_dialogue/30.html</link>
						<category>Call for dialogue</category>
						<pubDate>Sat, 07 Feb 2009 03:44:00 -0800</pubDate>
						<description>ILADS continues to push for open dialogue betwen professional.  Lisa Phillips of Neurology Times helped contribute to the dialogue.  The following sare quotations from the article that highlight the opportunities for dialogue.</description>
					</item>
				
			
		
<description>ILADS News</description>
</channel>
</rss>